An official website of the United States government Here's how you know

U.S. Department of Health and Human Services | National Institutes of Health

Official websites use .gov
A .gov website belongs to an official government
organization in the United States.

Secure .gov websites use HTTPS
A lock (🔒) or https:// means you've safely connected to the .gov website.
Share sensitive information only on official, secure websites.

NIH Guide: Weekly Index for October 21, 2022

Weekly NIH Guide Notices

October 21, 2022

Policy Notices

Notice of Clarification Regarding Data Management Plan Requirement for AHRQ National Research Service Award Institutional Research Training Grant (T32) RFA-HS-22-010
(NOT-HS-23-001)

Agency for Healthcare Research and Quality

General Notices

Notice of Correction to RFA-CA-22-013, PDX Data Commons and Coordinating Center (PDCCC) for the PDX Development and Trial Centers Research Network (PDXNet) (U24 Clinical Trial Not Allowed)
(NOT-CA-22-136)

National Cancer Institute
Notice of Pre-Application Webinar and FAQs for the Funding Opportunity Announcement Clinical Sites for HIV/Cervical Cancer Prevention 'CASCADE' Clinical Trials Network (UG1 Clinical Trial Required) (RFA-CA-22-051)
(NOT-CA-23-008)

National Cancer Institute
Pre-Application Webinar for NCIs FOAs on Advancing Adolescent Tobacco Cessation Intervention Research (RFA-CA-22-042, RFA-CA-22-43)
(NOT-CA-23-009)

National Cancer Institute
Notice to Extend the Response Date for NIH Guide NOT-DE-22-019, RFI: Request for Information on Augmenting Research Training and Engaging Scientists in Dental, Oral, and Craniofacial Research Careers
(NOT-DE-22-020)

National Institute of Dental and Craniofacial Research
Notice of Corrected Application Forms for RFA DE-23-009 Harnessing Technologies to Support Oral Health Promotion and Management Outside the Dental Setting (UG3/UH3 Clinical Trial Required)
(NOT-DE-23-001)

National Institute of Dental and Craniofacial Research
Clarification of Eligibility for Institutions with Multiple Campuses in PAR-21-169 "Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed)"
(NOT-GM-23-006)

National Institute of General Medical Sciences
Clarification of Eligibility for Institutions with Multiple Campuses in PAR-21-173 "Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed)"
(NOT-GM-23-007)

National Institute of General Medical Sciences
Notice of NICHD Participation in PAR-22-242, "Bioengineering Research Grants (BRG) (R01 Clinical Trial Not Allowed)"
(NOT-HD-22-050)

Eunice Kennedy Shriver National Institute of Child Health and Human Development
Notice of NICHD Participation in PAR-22-243, "Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional)"
(NOT-HD-22-051)

Eunice Kennedy Shriver National Institute of Child Health and Human Development
Notice of NICHD Participation in RFA-OD-22-015, "Galvanizing Health Equity Through Novel and Diverse Educational Resources (GENDER) Research Education (R25 Clinical Trial Not Allowed)
(NOT-HD-22-053)

Eunice Kennedy Shriver National Institute of Child Health and Human Development
Notice of Frequently Asked Questions (FAQs) for Multi-Omics for Health and Disease RFA-HG-22-008, RFA-HG-22-009, RFA-HG-22-010
(NOT-HG-23-011)

National Human Genome Research Institute
Notice of Information: Research Opportunity Announcement OTA-20-014-C IMPROVE Community Implementation Program (IMPROVE-CIP) Solicitation for Research Coalitions
(NOT-HL-22-054)

National Heart, Lung, and Blood Institute
The NIH Office of Disease Prevention (ODP) Announces the Pathways to Prevention Workshop: Identifying Risks and Interventions to Optimize Postpartum Health
(NOT-OD-23-010)

Office of Disease Prevention
Request for Information (RFI): Soliciting Input on the Use and Reuse of Cancer Metabolomics Data
(NOT-CA-23-007)

National Cancer Institute

Notice of Changes to Funding Opportunities

Notice to Clarify Eligibility Requirements of Program Directors/Principal Investigators (PDs/PIs) in PAR-21-295 NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Independent Clinical Trial Not Allowed)
(NOT-CA-22-137)

National Cancer Institute
Notice of Correction of Key Dates in RFA-CA-22-042, Advancing Adolescent Tobacco Cessation Intervention Research (R34 Clinical Trial Optional)
(NOT-CA-23-003)

National Cancer Institute
Notice of Change to The Page Limits for RFA-HG-22-027, "Diversity Centers for Genome Research (UG3/UH3 Clinical Trials Optional)"
(NOT-HG-23-010)

National Human Genome Research Institute

Notices of Intent to Publish

Notice of Intent to Publish a Funding Opportunity Announcement for the National Institute on Aging (NIA) Alzheimer's Disease (AD) and Alzheimer's Disease-Related Dementias (ADRD) Real-World Data (RWD) Platform Initiative (U54 Clinical Trial Required)
(NOT-AG-22-044)

National Institute on Aging

Notices of Special Interest

Notice of Special Interest (NOSI): Utilization of Cohorts and Prospective Study Designs for Liquid Biopsy Assay Validation for Early Detection of Cancers
(NOT-CA-23-004)

National Cancer Institute
Notice of Special Interest (NOSI): Research on the Impact of Policy Changes and Emerging and Evolving Public Health Crises on NIDA Populations of Interest
(NOT-DA-22-084)

National Institute on Drug Abuse

Funding Opportunities

Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (DP1 Clinical Trial Optional)
(PAR-23-021)

National Institute on Drug Abuse

Application Receipt Date(s): Multiple dates, see announcement.
NCMRR Early Career Research Award (R03 Clinical Trial Optional)
(PAR-23-029)

Eunice Kennedy Shriver National Institute of Child Health and Human Development

Application Receipt Date(s): Multiple dates, see announcement.
Research Networks to Promote Multidisciplinary Mechanistic Studies on Music-Based Interventions for Pain or Alzheimers Disease and Alzheimers Disease Related Dementias (AD/ADRD) (U24 Clinical Trial Optional)
(RFA-AT-23-006)

National Center for Complementary and Integrative Health

National Institute on Aging

Application Receipt Date(s): January 10, 2023
Avenir Award Program for Chemistry and Pharmacology of Substance Use Disorders (DP1- Clinical Trial Not Allowed)
(RFA-DA-24-007)

National Institute on Drug Abuse

Application Receipt Date(s): August 7, 2025
Toward ElucidAting MechanismS of HIV Pathogenesis within the Mission of the NIDDK (Pathogenesis TEAMS) (R01 Clinical Trial Optional)
(RFA-DK-22-039)

National Institute of Diabetes and Digestive and Kidney Diseases

Application Receipt Date(s): Not Applicable
Utilizing Telomere Status to Reveal Molecular Mechanisms Underlying Susceptibility and Resiliency in Response to Environmental Exposures (R01 Clinical Trial Not Allowed)
(RFA-ES-22-007)

National Institute of Environmental Health Sciences

Application Receipt Date(s): February 14, 2023

For technical issues E-mail OER Webmaster